Technology
Health
Pharmaceutical

Sutro Biopharma

$11.17
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (1.27%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell STRO and other stocks, options, ETFs, and crypto commission-free!

About STRO

Sutro Biopharma Inc. engages in the drug discovery, development and manufacturing of pharmaceutical products. Its products technologies include XpressCF, anti-body drug conjugates, bispecifics & engineered antibodies and cGMP facility. Read More The company was founded by James R. Swartz and Sutanto Widjaja in June 2003 and is headquartered in South San Francisco, CA.

Employees
158
Headquarters
South San Francisco, California
Founded
2003
Market Cap
252.87M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
15.59K
High Today
$11.78
Low Today
$10.96
Open Price
$11.78
Volume
57.94K
52 Week High
$15.90
52 Week Low
$8.50

Collections

Technology
Health
Pharmaceutical
Manufacturing
2018 IPO
US
North America

STRO News

Yahoo FinanceJun 18

Sutro Biopharma to Present at the JMP Securities Life Sciences Conference

5

STRO Earnings

-$21.26
-$14.23
-$7.19
-$0.16
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 14, After Hours

More STRO News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.